Assessment of bronchodilator responsiveness to salbutamol or ipratropium using different criteria in treatment-naïve patients with asthma and COPD
Background The criteria for significant bronchodilator responsiveness (BDR) were published in 2005 by the European Respiratory Society/American Thoracic Society, which were revised in 2021, however, data on the agreement between these two recommendations in untreated patients with airflow limitation...
Autores principales: | Zsófia Lázár, Alpár Horváth, Szilvia Kiss-Dala, Zsolt Abonyi-Tóth, Balázs Csoma, Katalin Kontz, Lilla Tamási, Veronika Müller |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Taylor & Francis Group
2024-12-01
|
Colección: | European Clinical Respiratory Journal |
Materias: | |
Acceso en línea: | https://www.tandfonline.com/doi/10.1080/20018525.2024.2328434 |
Ejemplares similares
-
Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator
por: Mona Ibrahim Ahmed, et al.
Publicado: (2023-10-01) -
Comparative study of the bronchodilator efficacy and adverse effects of salbutamol and hyoscine butylbromide in horses with severe asthma
por: Berta Mozo Vives, et al.
Publicado: (2024-05-01) -
A comparative study of bronchodilator response: utilizing pre-bronchodilator versus predicted normal values
por: Afe Alexis, et al.
Publicado: (2024-01-01) -
Circulating microRNAs associated with bronchodilator response in childhood asthma
por: Rinku Sharma, et al.
Publicado: (2024-11-01) -
Assessing sterility techniques in bronchodilator responsiveness testing by practicing allergists in North America
por: Kabir Chhabra, MD, et al.
Publicado: (2024-11-01)